
News|Slideshows|March 27, 2025
Emerging Research and News in Prostate Cancer Imaging — March 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in March 2025.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from monitoring of prostate MRI exams to reduce contrast use to a new meta-analysis on AI and bpMRI for csPCa detection and FDA approval of Gozellix for the preparation of the PSMA PET agent 68Ga gozetotide, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for March 2025.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Study Suggests FDG-PET Better than CT for Assessing Treatment Response for Metastatic Breast Cancer
2
A Closer Look at the Evolution and Emerging Insights with Amyloid and Tau PET for Dementia and Alzheimer’s Disease
3
Research Highlights from SCCT 2026
4
New Radiology Platform Facilitates Remote Access to Imaging and Collaboration
5













